Behavioural and biochemical adaptations to nicotine in rats: Influence of MK801, an NMDA receptor antagonist

Psychopharmacology

Volumn 134, Issue 2, 1997, Pages 121-130

  Shoaib, Mohammed ^a,c   Schindler, Charles W ^a   Goldberg, Steven R ^a   Pauly, James R ^b  

^a NIDA Addiction Research Center   (United States)

^b University of Kentucky   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

MK801; Nicotine; NMDA receptor; Rats

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NICOTINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; HYPOTHESIS; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR UPREGULATION; SENSITIZATION;

ALKALOIDS; ANIMALS; AUTORADIOGRAPHY; AZOCINES; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; NICOTINE; NICOTINIC AGONISTS; QUINOLIZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NICOTINIC; UP-REGULATION;

EID: 0030776043     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050433     Document Type: Article

References (30)

1. Amador M, Dani JA (1991) MK-801 inhibition of nicotinic acetylcholine receptor channels. Synapse 7:207-215
2. 3H]nicotine binding sites in human brain. J Neurochem 50:1243-1247
3. Clarke PBS, Fu DS, Jakubovic A, Fibiger HC (1988) Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. J Pharmacol Exp Ther 246: 701-708
4. Collins AC, Marks MJ (1996) Are nicotinic receptors activated or inhibited following chronic nicotine treatment? Drug Dev Res 38:231-242
5. El-Bizri H, Clarke PBS (1994) Regulation of nicotinic receptors in rat brain following quasi-irreversible nicotinic blockade by chlorisondamine and chronic treatment with nicotine. Br J Pharmacol 111:917-925
6. Goudie AJ, Emmett-Oglesby MW (1989) Psychoactive drugs: tolerance and sensitisation. Humana Press, Clifton. New Jersey
7. Huettner JE, Bean BP (1988) Blockade of NMDA-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl Acad Sci USA 85:1307-1311
8. Hulihan-Giblin BA, Lumpkin MD, Kellar KJ (1990) Effect of chronic administration of nicotine on prolactin release in the rat: inactivation of prolactin response by repeated injections of nicotine. J Pharmacol Exp Ther 252:21-25
9. Imperato A, Mulas A, Di Chiara G (1986) Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 132:337-338
10. Ksir CJ, Hakan RL, Kellar KJ (1987) Chronic nicotine and locomotor activity: influences of exposure dose and test dose. Psychopharmacology 92:25-29
11. Marks MJ, Burch JB, Collins AC (1983) Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J Pharmacol Exp Ther 226:817-825
12. Marks MJ, Stitzel JA, Collins AC (1985) Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J Pharmacol Exp Ther 235:619-628
13. Marshall DL, Redfern PH, Wonnacott S (1997) Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats. J Neurochem 68:1511-1519
14. Morrison CF, Stephenson JA (1972) The occurrence of tolerance to a central depressant effect of nicotine. Br J Pharmacol 46: 151-156
15. Museo E, Wise RA (1990) Microinjections of a nicotinic agonist into dopamine terminal fields: effects on locomotion. Pharmac Biochem Behav 37:113-116
16. Pauly JR, Collins AC (1993) An autoradiographic analysis of nicotinic cholinergic receptors following chronic corticosterone treatment. Neuroendocrinology 57:262-271
17. Pauly JR, Marks MJ, Stitzel JA, Gross SD, Collins AC (1991) Chronic nicotine infusions and regulation of CNS nicotinic cholinergic receptors: an autoradiographic study. J Pharmacol Exp Ther 258:1127-1136
18. Pauly JR, Marks MJ, Robinson SF, van de Kamp JL, Collins AC (1996) Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without accompanying changes in 4 or 2 mRNA. J Pharmacol Exp Ther 278:361-369
19. Porter RHP, Greenamyre JT (1994) Inhibition of autoradiographic MK-801 binding by an endogenous factor. Neurosci Lett 169: 105-108
20. Ramoa AS, Alkondon M, Aracava Y, Irons J, Lunt GG, Desphande SS, Wonnacott S, Aronstam RS, Albuquerque EX (1990) The anticonvulsant MK-801 interacts with the peripheral and central nicotinic acetylcholine receptor ion channels. J Pharmacol Exp Ther 254:71-82
21. Schenk S, Valadez A, McNamara C, House DT, Higley D, Bankson MG, Horger BA (1993) Development and expression of sensitization to cocaine's reinforcing properties: role of NMDA receptors. Psychopharmacology 111:332-338
22. 3H)acetylcholine recognition sites in brain by nieotinic cholinergic drugs. J Neurochem 45:427-433
23. Shoaib M, Stolerman IP (1992) MK801 attenuates behavioural adaptation to chronic nicotine administration in rats. Br J Pharmacol 105:514-515
24. Shoaib M, Stolerman IP (1996) The NMDA antagonist dizocilpine (MK801) attenuates tolerance to nicotine in rats. J Psychopharmacol 10:214-218
25. Shoaib M, Benwell MEM, Akbar MT, Stolerman IP, Balfour DJK (1994) Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists. Br J Pharmacol 111:1073-1080
26. Siewart J, Druhan JP (1993) Development of both conditioning and sensitization of the behavioural activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist. Psychopharmacology 110:125-132
27. Stolerman IP, Bunker P, Jarvik ME (1974) Nicotine tolerance in rats: role of dose and dose interval. Psychopharmacologia 34: 317-324
28. Trujillo KA, Akil H (1995) Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence. Drug Alcohol Depend 38:139-154
29. Wong EF, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL (1986) The antieonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci USA 83: 7104-7108
30. Zhang X, Gong Z, Nordberg A (1997) Effects of chronic treatment with (+)- and (-)-nicotine on nicotinic acetylcholine receptors and N-methyl-D-aspartate receptors in rat brain. Brain Res 644: 32-39